Covington Reps Bristol-Myers In $325M Amira Buy
New York-based Bristol-Myers will acquire all of the outstanding shares in the privately held Amira, it said. Apart from the upfront payment, the deal includes potential future milestone payments that could total $150 million, the company said.
The purchase gives the pharmaceutical giant control of California-based Amira's fibrosis program, including a prototype drug...
To view the full article, register now.